Enhancing Obesity Treatment Pricing in South Af...

By João L. Carapinha

April 2, 2026

Novo Nordisk has cut the price of Wegovy for the second time in South Africa, making obesity treatment pricing South Africa a key focus for improved patient access. The latest reductions, announced on 25 March 2026, lower the lowest injectable dos...
Personalised Fertility Endometriosis Care in the UK
Tarlatamab for Small Cell Lung Cancer Treatment
FDA Approves Once-Weekly Basal Insulin Awiqli® for Type 2 Diabetes Management
EU Alzheimer Approval Challenges: Anavex Withdraws Blarcamesine Application A...
NICE Pembrolizumab Recommendation for Locally Advanced Head and Neck Cancer T...
PEPFAR TB Impact: Averting Millions of Cases and Deaths Among HIV Patients
Vitamin B6 Depletion Risk in Carbidopa/Levodopa Therapy and Seizure Implications
Advancing Collaborative TB Innovation to Tackle Drug Resistance
Serplulimab Lung Cancer Treatment: Evaluation of Clinical and Economic Impact...
Cost-Effectiveness of T1D Screening Effectiveness in Canadian Children
Novartis Acquires Mutant-Selective PI3Kα Inhibitor to Enhance Breast Cancer T...
Semaglutide India Partnership: Enhancing Access to Diabetes Treatment